Company Monitoring Page for Novo-Nordisk

latest headlines for company on cafepharma

Big-sellers from Merck, Novo and Lilly likely to face Medicare price negotiations: report
Fierce Pharma
Tue, 02/28/23 - 10:39 pm
Tags:
Medicare, drug pricing, Merck, Novo Nordisk, Eli Lilly, Boehringer Ingelheim, JNJ
Novo sows the seeds for a new heart failure approach
EP Vantage
Wed, 02/22/23 - 09:50 am
Tags:
Novo Nordisk, HS-001, cell therapy, heart failure
Novo Nordisk apologizes for not disclosing sponsorship of anti-obesity training
Financial Times
Mon, 02/13/23 - 10:44 am
Tags:
Novo Nordisk, obesity, UK, Saxenda
Heart hope for Heartseed/Novo Nordisk HS-001 cell therapy
Pharmaphorum
Fri, 02/10/23 - 10:21 am
Tags:
Novo Nordisk, Heartseed, clinical trials, HS-001, cell therapy, heart failure
Novo Nordisk notches big GLP-1 sales amid rebounding supplies, but cautions on future 'periodic constraints'
Endpoints
Thu, 02/2/23 - 10:46 am
Tags:
Novo Nordisk, Wegovy, earnings
AstraZeneca, Novo Nordisk and Sanofi score 340B-related appeals court win over HHS
Endpoints
Mon, 01/30/23 - 05:58 pm
Tags:
AstraZeneca, Sanofi, Novo Nordisk, 340B, drug discounts
Top 10 Pharma TV Ad Spenders in 2022 — Anti-Inflammatories and Diabetes Drugs Dominate
Xtalks
Sun, 01/29/23 - 01:31 pm
Tags:
television ads, pharma marketing, DTC ads, AbbVie, Rinvoq, Dupixent, Sanofi, Regeneron, Skyrizi, Novo Nordisk, Ozempic, Jardiance, Eli Lilly, Boehringer Ingelheim, Rybelsus, Trulicity, Rexulti, Otsuka, Lundbeck, Tremfya, JNJ, Verzenio
Big caps bounce back for biopharma
EP Vantage
Mon, 01/16/23 - 11:14 am
Tags:
pharma stocks, Amgen, BeiGene, Bristol Myers Squibb, Gilead Sciences, Lantheus Holdings, Madrigal Pharmaceuticals, Merck, Moderna Therapeutics, Novo Nordisk, Prometheus Biosciences, Roche
Novo Nordisk's GLP-1 for Type II diabetes approved for first-line treatment
Endpoints
Fri, 01/13/23 - 11:10 am
Tags:
Novo Nordisk, Rybelsus, semaglutide, FDA, type 2 diabetes, diabetes
Novo Nordisk, AstraZeneca and Lilly will top pharma's revenue growth in 2023: report
Fierce Pharma
Sun, 01/8/23 - 09:57 pm
Tags:
Pfizer, Merck, JNJ, Novo Nordisk, AstraZeneca
Novo Nordisk to go slow on Wegovy marketing after getting supply issues in check
Medical Marketing and Media
Thu, 01/5/23 - 04:54 pm
Tags:
Novo Nordisk, obesity, Wegovy, pharma marketing
Big pharma’s new year catalysts
EP Vantage
Mon, 12/19/22 - 11:05 am
Tags:
AstraZeneca, Daiichi Sankyo, Pfizer, Roche, CSL, uniQure, Novo Nordisk, Eli Lilly
Despite flu admissions rising, Tamiflu fill rates are on the decline
Beckers Hospital Review
Thu, 12/15/22 - 11:18 pm
Tags:
Flu, Tamiflu, Novo Nordisk
Novo Nordisk comments on role of off-label use in Ozempic shortfall
Medical Marketing and Media
Thu, 12/15/22 - 10:56 am
Tags:
Novo Nordisk, Ozempic, diabetes, off label, drug shortages
‘Diabesity’ marketing set to swell as Novo preps relaunch of weight-loss drug
Medical Marketing and Media
Wed, 12/14/22 - 10:36 am
Tags:
Novo Nordisk, pharma marketing, Wegovy, obesity, diabetes
NASH: Wall Street’s Forgotten Mega Blockbuster Indication
BioSpace
Mon, 12/12/22 - 10:13 am
Tags:
NASH, Intercept Pharma, Novo Nordisk, Madrigal Pharmaceuticals, Inventiva, Galmed Pharmaceuticals
Amgen to push latecomer obesity drug into midstage testing
Pharmaphorum
Sun, 12/4/22 - 01:26 pm
Tags:
Amgen, Novo Nordisk, Eli Lilly, obesity, clinical trials, AMG 133
Novo Nordisk invests $74M to boost API manufacturing for clinical trials
Fierce Biotech
Tue, 11/22/22 - 10:52 am
Tags:
Novo Nordisk, clinical trials, APIs, API manufacturing, R&D
Looming obesity drug rivalry not a concern for Novo CEO
Reuters
Wed, 11/16/22 - 10:42 am
Tags:
Novo Nordisk, Wegovy, obesity
Lumos' oral growth hormone drug falls short of Novo's injectable incumbent at interim analysis
Fierce Pharma
Tue, 11/15/22 - 11:06 am
Tags:
Lumos Pharma, growth hormone, Novo Nordisk, clinical trials

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.